Neurodiagnostics Market Research Report by Product (Clinical Testing Instrument, Diagnostic & Imaging System, and Reagent & Consumable), by Indication (Epilepsy, Headache Disorder, Neurodegenerative Diseases, Sleep Disorder, and Stroke), by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Neurodiagnostics Market is expected to grow from USD 5,765.18 Million in 2020 to USD 8,349.12 Million by the end of 2025.
2. The Global Neurodiagnostics Market is expected to grow from EUR 5,055.02 Million in 2020 to EUR 7,320.66 Million by the end of 2025.
3. The Global Neurodiagnostics Market is expected to grow from GBP 4,493.93 Million in 2020 to GBP 6,508.08 Million by the end of 2025.
4. The Global Neurodiagnostics Market is expected to grow from JPY 615,291.86 Million in 2020 to JPY 891,062.67 Million by the end of 2025.
5. The Global Neurodiagnostics Market is expected to grow from AUD 8,371.82 Million in 2020 to AUD 12,124.03 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Neurodiagnostics to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product, the Neurodiagnostics Market studied across Clinical Testing Instrument, Diagnostic & Imaging System, and Reagent & Consumable. The Clinical Testing Instrument further studied across NGS Instrument, PCR Instrument, and Sanger Sequencer. The Diagnostic & Imaging System further studied across Angiography System, CT Scanner, EEG System, EMG Device, MEG Device, MRI System, PET Scanner, and Ultrasound Imaging System. The Reagent & Consumable further studied across Antibody, Buffer, Enzyme, Protein, & Peptide, Media & Sera, Probe, and Solvent.
Based on Indication, the Neurodiagnostics Market studied across Epilepsy, Headache Disorder, Neurodegenerative Diseases, Sleep Disorder, and Stroke.
Based on End User, the Neurodiagnostics Market studied across Diagnostic Laboratory & Imaging Center, Hospital & Clinic, Ambulatory Care Center, and Neurology Center.
'The Asia-Pacific is projected to witness the highest growth during the forecast period'
Based on Geography, the Neurodiagnostics Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Americas commanded the largest size in the Neurodiagnostics Market in 2020. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Neurodiagnostics Market including Advanced Brain Monitoring, Inc., Bio-Rad Laboratories, Canon, Inc., F. Hoffmann-La Roche AG, FUJIFILM Holdings Corporation, GE Healthcare, Hitachi, Ltd., Lifelines Neuro Company, LLC, Mitsar Co., Ltd., Natus Medical Incorporated, Nihon Kohden Corporation, Philips Healthcare, QIAGEN N.V., Siemens Healthineers, and Thermo Fisher Scientific, Inc..
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Neurodiagnostics Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Neurodiagnostics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Neurodiagnostics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Neurodiagnostics Market?
4. What is the competitive strategic window for opportunities in the Global Neurodiagnostics Market?
5. What are the technology trends and regulatory frameworks in the Global Neurodiagnostics Market?
6. What are the modes and strategic moves considered suitable for entering the Global Neurodiagnostics Market?
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Neurodiagnostics Market is expected to grow from USD 5,765.18 Million in 2020 to USD 8,349.12 Million by the end of 2025.
2. The Global Neurodiagnostics Market is expected to grow from EUR 5,055.02 Million in 2020 to EUR 7,320.66 Million by the end of 2025.
3. The Global Neurodiagnostics Market is expected to grow from GBP 4,493.93 Million in 2020 to GBP 6,508.08 Million by the end of 2025.
4. The Global Neurodiagnostics Market is expected to grow from JPY 615,291.86 Million in 2020 to JPY 891,062.67 Million by the end of 2025.
5. The Global Neurodiagnostics Market is expected to grow from AUD 8,371.82 Million in 2020 to AUD 12,124.03 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Neurodiagnostics to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product, the Neurodiagnostics Market studied across Clinical Testing Instrument, Diagnostic & Imaging System, and Reagent & Consumable. The Clinical Testing Instrument further studied across NGS Instrument, PCR Instrument, and Sanger Sequencer. The Diagnostic & Imaging System further studied across Angiography System, CT Scanner, EEG System, EMG Device, MEG Device, MRI System, PET Scanner, and Ultrasound Imaging System. The Reagent & Consumable further studied across Antibody, Buffer, Enzyme, Protein, & Peptide, Media & Sera, Probe, and Solvent.
Based on Indication, the Neurodiagnostics Market studied across Epilepsy, Headache Disorder, Neurodegenerative Diseases, Sleep Disorder, and Stroke.
Based on End User, the Neurodiagnostics Market studied across Diagnostic Laboratory & Imaging Center, Hospital & Clinic, Ambulatory Care Center, and Neurology Center.
'The Asia-Pacific is projected to witness the highest growth during the forecast period'
Based on Geography, the Neurodiagnostics Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Americas commanded the largest size in the Neurodiagnostics Market in 2020. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Neurodiagnostics Market including Advanced Brain Monitoring, Inc., Bio-Rad Laboratories, Canon, Inc., F. Hoffmann-La Roche AG, FUJIFILM Holdings Corporation, GE Healthcare, Hitachi, Ltd., Lifelines Neuro Company, LLC, Mitsar Co., Ltd., Natus Medical Incorporated, Nihon Kohden Corporation, Philips Healthcare, QIAGEN N.V., Siemens Healthineers, and Thermo Fisher Scientific, Inc..
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Neurodiagnostics Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Neurodiagnostics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Neurodiagnostics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Neurodiagnostics Market?
4. What is the competitive strategic window for opportunities in the Global Neurodiagnostics Market?
5. What are the technology trends and regulatory frameworks in the Global Neurodiagnostics Market?
6. What are the modes and strategic moves considered suitable for entering the Global Neurodiagnostics Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Product Outlook
3.4. Indication Outlook
3.5. End User Outlook
3.6. Geography Outlook
3.7. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidences of neurological disorders worldwide
5.1.1.2. Growing awareness among patients for early disease diagnosis for effective treatment
5.1.1.3. Growing adoption of innovative diagnostic technologies
5.1.2. Restraints
5.1.2.1. Limited availability of skilled healthcare professionals
5.1.3. Opportunities
5.1.3.1. Advances in genomics and proteomics for neurodegenerative disorders diagnosis
5.1.3.2. Ongoing clinical trials
5.1.4. Challenges
5.1.4.1. High cost associated with the neurodiagnostic devices
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL NEURODIAGNOSTICS MARKET, BY PRODUCT
6.1. Introduction
6.2. Clinical Testing Instrument
6.2.1. NGS Instrument
6.2.2. PCR Instrument
6.2.3. Sanger Sequencer
6.3. Diagnostic & Imaging System
6.3.1. Angiography System
6.3.2. CT Scanner
6.3.3. EEG System
6.3.4. EMG Device
6.3.5. MEG Device
6.3.6. MRI System
6.3.7. PET Scanner
6.3.8. Ultrasound Imaging System
6.4. Reagent & Consumable
6.4.1. Antibody
6.4.2. Buffer
6.4.3. Enzyme, Protein, & Peptide
6.4.4. Media & Sera
6.4.5. Probe
6.4.6. Solvent
7. GLOBAL NEURODIAGNOSTICS MARKET, BY INDICATION
7.1. Introduction
7.2. Epilepsy
7.3. Headache Disorder
7.4. Neurodegenerative Diseases
7.5. Sleep Disorder
7.6. Stroke
8. GLOBAL NEURODIAGNOSTICS MARKET, BY END USER
8.1. Introduction
8.2. Diagnostic Laboratory & Imaging Center
8.3. Hospital & Clinic
8.4. Ambulatory Care Center
8.5. Neurology Center
9. AMERICAS NEURODIAGNOSTICS MARKET
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. ASIA-PACIFIC NEURODIAGNOSTICS MARKET
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. South Korea
10.10. Thailand
11. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. COMPETITIVE LANDSCAPE
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis
12.4. Competitor SWOT Analysis
12.5. Competitive Scenario
12.5.1. Merger & Acquisition
12.5.2. Agreement, Collaboration, & Partnership
12.5.3. New Product Launch & Enhancement
12.5.4. Investment & Funding
12.5.5. Award, Recognition, & Expansion
13. COMPANY USABILITY PROFILES
13.1. Advanced Brain Monitoring, Inc.
13.2. Bio-Rad Laboratories
13.3. Canon, Inc.
13.4. F. Hoffmann-La Roche AG
13.5. FUJIFILM Holdings Corporation
13.6. GE Healthcare
13.7. Hitachi, Ltd.
13.8. Lifelines Neuro Company, LLC
13.9. Mitsar Co., Ltd.
13.10. Natus Medical Incorporated
13.11. Nihon Kohden Corporation
13.12. Philips Healthcare
13.13. QIAGEN N.V.
13.14. Siemens Healthineers
13.15. Thermo Fisher Scientific, Inc.
14. APPENDIX
14.1. Discussion Guide
14.2. License & Pricing
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Product Outlook
3.4. Indication Outlook
3.5. End User Outlook
3.6. Geography Outlook
3.7. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidences of neurological disorders worldwide
5.1.1.2. Growing awareness among patients for early disease diagnosis for effective treatment
5.1.1.3. Growing adoption of innovative diagnostic technologies
5.1.2. Restraints
5.1.2.1. Limited availability of skilled healthcare professionals
5.1.3. Opportunities
5.1.3.1. Advances in genomics and proteomics for neurodegenerative disorders diagnosis
5.1.3.2. Ongoing clinical trials
5.1.4. Challenges
5.1.4.1. High cost associated with the neurodiagnostic devices
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL NEURODIAGNOSTICS MARKET, BY PRODUCT
6.1. Introduction
6.2. Clinical Testing Instrument
6.2.1. NGS Instrument
6.2.2. PCR Instrument
6.2.3. Sanger Sequencer
6.3. Diagnostic & Imaging System
6.3.1. Angiography System
6.3.2. CT Scanner
6.3.3. EEG System
6.3.4. EMG Device
6.3.5. MEG Device
6.3.6. MRI System
6.3.7. PET Scanner
6.3.8. Ultrasound Imaging System
6.4. Reagent & Consumable
6.4.1. Antibody
6.4.2. Buffer
6.4.3. Enzyme, Protein, & Peptide
6.4.4. Media & Sera
6.4.5. Probe
6.4.6. Solvent
7. GLOBAL NEURODIAGNOSTICS MARKET, BY INDICATION
7.1. Introduction
7.2. Epilepsy
7.3. Headache Disorder
7.4. Neurodegenerative Diseases
7.5. Sleep Disorder
7.6. Stroke
8. GLOBAL NEURODIAGNOSTICS MARKET, BY END USER
8.1. Introduction
8.2. Diagnostic Laboratory & Imaging Center
8.3. Hospital & Clinic
8.4. Ambulatory Care Center
8.5. Neurology Center
9. AMERICAS NEURODIAGNOSTICS MARKET
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. ASIA-PACIFIC NEURODIAGNOSTICS MARKET
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. South Korea
10.10. Thailand
11. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. COMPETITIVE LANDSCAPE
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis
12.4. Competitor SWOT Analysis
12.5. Competitive Scenario
12.5.1. Merger & Acquisition
12.5.2. Agreement, Collaboration, & Partnership
12.5.3. New Product Launch & Enhancement
12.5.4. Investment & Funding
12.5.5. Award, Recognition, & Expansion
13. COMPANY USABILITY PROFILES
13.1. Advanced Brain Monitoring, Inc.
13.2. Bio-Rad Laboratories
13.3. Canon, Inc.
13.4. F. Hoffmann-La Roche AG
13.5. FUJIFILM Holdings Corporation
13.6. GE Healthcare
13.7. Hitachi, Ltd.
13.8. Lifelines Neuro Company, LLC
13.9. Mitsar Co., Ltd.
13.10. Natus Medical Incorporated
13.11. Nihon Kohden Corporation
13.12. Philips Healthcare
13.13. QIAGEN N.V.
13.14. Siemens Healthineers
13.15. Thermo Fisher Scientific, Inc.
14. APPENDIX
14.1. Discussion Guide
14.2. License & Pricing
LIST OF TABLES
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL NEURODIAGNOSTICS MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY NGS INSTRUMENT, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY PCR INSTRUMENT, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY SANGER SEQUENCER, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY ANGIOGRAPHY SYSTEM, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY CT SCANNER, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY EEG SYSTEM, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY EMG DEVICE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY MEG DEVICE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY MRI SYSTEM, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY PET SCANNER, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY ULTRASOUND IMAGING SYSTEM, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY ANTIBODY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY BUFFER, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY ENZYME, PROTEIN, & PEPTIDE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY MEDIA & SERA, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY PROBE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY SOLVENT, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY HEADACHE DISORDER, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY NEURODEGENERATIVE DISEASES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY SLEEP DISORDER, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY STROKE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORY & IMAGING CENTER, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY HOSPITAL & CLINIC, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTER, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY NEUROLOGY CENTER, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. CANADA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. CANADA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. CANADA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. AUSTRALIA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. AUSTRALIA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. AUSTRALIA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. CHINA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. CHINA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. CHINA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. INDIA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. INDIA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. INDIA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. INDONESIA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. INDONESIA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. INDONESIA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. JAPAN NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. JAPAN NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. JAPAN NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. MALAYSIA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. MALAYSIA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. MALAYSIA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. PHILIPPINES NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. PHILIPPINES NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. PHILIPPINES NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. SOUTH KOREA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. SOUTH KOREA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. SOUTH KOREA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. THAILAND NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. THAILAND NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. THAILAND NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. FRANCE NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. FRANCE NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. FRANCE NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. GERMANY NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. GERMANY NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. GERMANY NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. ITALY NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. ITALY NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. ITALY NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. NETHERLANDS NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. NETHERLANDS NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. NETHERLANDS NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. QATAR NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. QATAR NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. QATAR NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. RUSSIA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 106. RUSSIA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 107. RUSSIA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 108. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 109. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 110. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 111. SOUTH AFRICA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 112. SOUTH AFRICA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 113. SOUTH AFRICA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 114. SPAIN NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 115. SPAIN NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 116. SPAIN NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 117. UNITED ARAB EMIRATES NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 118. UNITED ARAB EMIRATES NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 119. UNITED ARAB EMIRATES NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 120. UNITED KINGDOM NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 121. UNITED KINGDOM NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 122. UNITED KINGDOM NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 123. GLOBAL NEURODIAGNOSTICS MARKET: SCORES
TABLE 124. GLOBAL NEURODIAGNOSTICS MARKET: BUSINESS STRATEGY
TABLE 125. GLOBAL NEURODIAGNOSTICS MARKET: PRODUCT SATISFACTION
TABLE 126. GLOBAL NEURODIAGNOSTICS MARKET: RANKING
TABLE 127. GLOBAL NEURODIAGNOSTICS MARKET: MERGER & ACQUISITION
TABLE 128. GLOBAL NEURODIAGNOSTICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 129. GLOBAL NEURODIAGNOSTICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 130. GLOBAL NEURODIAGNOSTICS MARKET: INVESTMENT & FUNDING
TABLE 131. GLOBAL NEURODIAGNOSTICS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 132. GLOBAL NEURODIAGNOSTICS MARKET: LICENSE & PRICING
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL NEURODIAGNOSTICS MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY NGS INSTRUMENT, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY PCR INSTRUMENT, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY SANGER SEQUENCER, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY ANGIOGRAPHY SYSTEM, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY CT SCANNER, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY EEG SYSTEM, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY EMG DEVICE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY MEG DEVICE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY MRI SYSTEM, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY PET SCANNER, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY ULTRASOUND IMAGING SYSTEM, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY ANTIBODY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY BUFFER, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY ENZYME, PROTEIN, & PEPTIDE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY MEDIA & SERA, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY PROBE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY SOLVENT, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY HEADACHE DISORDER, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY NEURODEGENERATIVE DISEASES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY SLEEP DISORDER, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY STROKE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORY & IMAGING CENTER, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY HOSPITAL & CLINIC, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTER, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY NEUROLOGY CENTER, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. CANADA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. CANADA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. CANADA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. AUSTRALIA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. AUSTRALIA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. AUSTRALIA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. CHINA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. CHINA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. CHINA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. INDIA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. INDIA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. INDIA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. INDONESIA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. INDONESIA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. INDONESIA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. JAPAN NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. JAPAN NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. JAPAN NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. MALAYSIA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. MALAYSIA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. MALAYSIA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. PHILIPPINES NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. PHILIPPINES NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. PHILIPPINES NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. SOUTH KOREA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. SOUTH KOREA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. SOUTH KOREA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. THAILAND NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. THAILAND NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. THAILAND NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. FRANCE NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. FRANCE NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. FRANCE NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. GERMANY NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. GERMANY NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. GERMANY NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. ITALY NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. ITALY NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. ITALY NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. NETHERLANDS NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. NETHERLANDS NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. NETHERLANDS NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. QATAR NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. QATAR NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. QATAR NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. RUSSIA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 106. RUSSIA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 107. RUSSIA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 108. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 109. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 110. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 111. SOUTH AFRICA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 112. SOUTH AFRICA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 113. SOUTH AFRICA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 114. SPAIN NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 115. SPAIN NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 116. SPAIN NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 117. UNITED ARAB EMIRATES NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 118. UNITED ARAB EMIRATES NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 119. UNITED ARAB EMIRATES NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 120. UNITED KINGDOM NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 121. UNITED KINGDOM NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 122. UNITED KINGDOM NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 123. GLOBAL NEURODIAGNOSTICS MARKET: SCORES
TABLE 124. GLOBAL NEURODIAGNOSTICS MARKET: BUSINESS STRATEGY
TABLE 125. GLOBAL NEURODIAGNOSTICS MARKET: PRODUCT SATISFACTION
TABLE 126. GLOBAL NEURODIAGNOSTICS MARKET: RANKING
TABLE 127. GLOBAL NEURODIAGNOSTICS MARKET: MERGER & ACQUISITION
TABLE 128. GLOBAL NEURODIAGNOSTICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 129. GLOBAL NEURODIAGNOSTICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 130. GLOBAL NEURODIAGNOSTICS MARKET: INVESTMENT & FUNDING
TABLE 131. GLOBAL NEURODIAGNOSTICS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 132. GLOBAL NEURODIAGNOSTICS MARKET: LICENSE & PRICING
LIST OF FIGURES
FIGURE 1. GLOBAL NEURODIAGNOSTICS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL NEURODIAGNOSTICS MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL NEURODIAGNOSTICS MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2020 (USD MILLION)
FIGURE 5. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2020 (USD MILLION)
FIGURE 6. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2020 (USD MILLION)
FIGURE 7. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 8. GLOBAL NEURODIAGNOSTICS MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 9. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 10. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 12. GLOBAL NEURODIAGNOSTICS MARKET: MARKET DYNAMICS
FIGURE 13. GLOBAL NEURODIAGNOSTICS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 14. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2020 VS 2025 (%)
FIGURE 15. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2020 VS 2025 (USD MILLION)
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025
FIGURE 17. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY NGS INSTRUMENT, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY PCR INSTRUMENT, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY SANGER SEQUENCER, 2020 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2020 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY ANGIOGRAPHY SYSTEM, 2020 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY CT SCANNER, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY EEG SYSTEM, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY EMG DEVICE, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY MEG DEVICE, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY MRI SYSTEM, 2020 VS 2025 (USD MILLION)
FIGURE 28. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY PET SCANNER, 2020 VS 2025 (USD MILLION)
FIGURE 29. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY ULTRASOUND IMAGING SYSTEM, 2020 VS 2025 (USD MILLION)
FIGURE 30. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2020 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY ANTIBODY, 2020 VS 2025 (USD MILLION)
FIGURE 32. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY BUFFER, 2020 VS 2025 (USD MILLION)
FIGURE 33. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY ENZYME, PROTEIN, & PEPTIDE, 2020 VS 2025 (USD MILLION)
FIGURE 34. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY MEDIA & SERA, 2020 VS 2025 (USD MILLION)
FIGURE 35. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY PROBE, 2020 VS 2025 (USD MILLION)
FIGURE 36. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY SOLVENT, 2020 VS 2025 (USD MILLION)
FIGURE 37. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2020 VS 2025 (%)
FIGURE 38. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2020 VS 2025 (USD MILLION)
FIGURE 39. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2025
FIGURE 40. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2020 VS 2025 (USD MILLION)
FIGURE 41. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY HEADACHE DISORDER, 2020 VS 2025 (USD MILLION)
FIGURE 42. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2020 VS 2025 (USD MILLION)
FIGURE 43. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY SLEEP DISORDER, 2020 VS 2025 (USD MILLION)
FIGURE 44. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2020 VS 2025 (USD MILLION)
FIGURE 45. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2020 VS 2025 (%)
FIGURE 46. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2020 VS 2025 (USD MILLION)
FIGURE 47. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2025
FIGURE 48. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORY & IMAGING CENTER, 2020 VS 2025 (USD MILLION)
FIGURE 49. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY HOSPITAL & CLINIC, 2020 VS 2025 (USD MILLION)
FIGURE 50. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTER, 2020 VS 2025 (USD MILLION)
FIGURE 51. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY NEUROLOGY CENTER, 2020 VS 2025 (USD MILLION)
FIGURE 52. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 53. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 54. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 55. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. CANADA NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 61. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 62. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 63. AUSTRALIA NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. CHINA NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 65. INDIA NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 66. INDONESIA NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 67. JAPAN NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 68. MALAYSIA NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 69. PHILIPPINES NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 70. SOUTH KOREA NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 71. THAILAND NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 72. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 73. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 74. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 75. FRANCE NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 76. GERMANY NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 77. ITALY NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 78. NETHERLANDS NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 79. QATAR NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 80. RUSSIA NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 81. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 82. SOUTH AFRICA NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 83. SPAIN NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 84. UNITED ARAB EMIRATES NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 85. UNITED KINGDOM NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 86. GLOBAL NEURODIAGNOSTICS MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 87. GLOBAL NEURODIAGNOSTICS MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 88. GLOBAL NEURODIAGNOSTICS MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 89. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL NEURODIAGNOSTICS MARKET, BY TYPE
FIGURE 1. GLOBAL NEURODIAGNOSTICS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL NEURODIAGNOSTICS MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL NEURODIAGNOSTICS MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2020 (USD MILLION)
FIGURE 5. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2020 (USD MILLION)
FIGURE 6. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2020 (USD MILLION)
FIGURE 7. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 8. GLOBAL NEURODIAGNOSTICS MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 9. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 10. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 12. GLOBAL NEURODIAGNOSTICS MARKET: MARKET DYNAMICS
FIGURE 13. GLOBAL NEURODIAGNOSTICS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 14. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2020 VS 2025 (%)
FIGURE 15. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2020 VS 2025 (USD MILLION)
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025
FIGURE 17. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY NGS INSTRUMENT, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY PCR INSTRUMENT, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY SANGER SEQUENCER, 2020 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2020 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY ANGIOGRAPHY SYSTEM, 2020 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY CT SCANNER, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY EEG SYSTEM, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY EMG DEVICE, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY MEG DEVICE, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY MRI SYSTEM, 2020 VS 2025 (USD MILLION)
FIGURE 28. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY PET SCANNER, 2020 VS 2025 (USD MILLION)
FIGURE 29. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY ULTRASOUND IMAGING SYSTEM, 2020 VS 2025 (USD MILLION)
FIGURE 30. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2020 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY ANTIBODY, 2020 VS 2025 (USD MILLION)
FIGURE 32. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY BUFFER, 2020 VS 2025 (USD MILLION)
FIGURE 33. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY ENZYME, PROTEIN, & PEPTIDE, 2020 VS 2025 (USD MILLION)
FIGURE 34. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY MEDIA & SERA, 2020 VS 2025 (USD MILLION)
FIGURE 35. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY PROBE, 2020 VS 2025 (USD MILLION)
FIGURE 36. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY SOLVENT, 2020 VS 2025 (USD MILLION)
FIGURE 37. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2020 VS 2025 (%)
FIGURE 38. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2020 VS 2025 (USD MILLION)
FIGURE 39. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2025
FIGURE 40. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2020 VS 2025 (USD MILLION)
FIGURE 41. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY HEADACHE DISORDER, 2020 VS 2025 (USD MILLION)
FIGURE 42. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2020 VS 2025 (USD MILLION)
FIGURE 43. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY SLEEP DISORDER, 2020 VS 2025 (USD MILLION)
FIGURE 44. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2020 VS 2025 (USD MILLION)
FIGURE 45. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2020 VS 2025 (%)
FIGURE 46. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2020 VS 2025 (USD MILLION)
FIGURE 47. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2025
FIGURE 48. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORY & IMAGING CENTER, 2020 VS 2025 (USD MILLION)
FIGURE 49. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY HOSPITAL & CLINIC, 2020 VS 2025 (USD MILLION)
FIGURE 50. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTER, 2020 VS 2025 (USD MILLION)
FIGURE 51. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY NEUROLOGY CENTER, 2020 VS 2025 (USD MILLION)
FIGURE 52. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 53. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 54. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 55. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. CANADA NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 61. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 62. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 63. AUSTRALIA NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. CHINA NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 65. INDIA NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 66. INDONESIA NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 67. JAPAN NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 68. MALAYSIA NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 69. PHILIPPINES NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 70. SOUTH KOREA NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 71. THAILAND NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 72. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 73. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 74. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 75. FRANCE NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 76. GERMANY NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 77. ITALY NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 78. NETHERLANDS NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 79. QATAR NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 80. RUSSIA NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 81. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 82. SOUTH AFRICA NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 83. SPAIN NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 84. UNITED ARAB EMIRATES NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 85. UNITED KINGDOM NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 86. GLOBAL NEURODIAGNOSTICS MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 87. GLOBAL NEURODIAGNOSTICS MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 88. GLOBAL NEURODIAGNOSTICS MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 89. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL NEURODIAGNOSTICS MARKET, BY TYPE
